Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The company’s lead product candidate, Troxatyl(TM), is currently being evaluated in a pivotal Phase II/III trial for the treatment of third-line acute myelogenous leukemia. SGX has developed a pipeline of oncology drug candidates based on its enabling, proprietary FAST(TM) drug discovery platform, including next generation BCR-ABL inhibitors currently being developed in partnership with Novartis. FAST allows for the rapid identification of novel, potent and selective small molecule compounds for well validated but challenging targets. ( www.sgxpharma.com )
SGX Pharmaceuticals , Inc.
SGX Pharmaceuticals, Inc. 10505 Roselle Street
San Diego, California 92121
USA
Tel: (858) 558-4850
Fax: (858) 558-4859